FBXW7 and neoplasm: Exosomal miR-25-3p knocks down the F-box and WD repeat domain-containing-7 (FBXW7), a tumor suppressor, leading to glioblastoma cells’ resistance to temozolomide by enhancing the expression of c-Myc and cyclin E, which are known for their oncogenic properties [136].